Odisha CS Directs To Raise Awareness On Favipiravir Therapy In Home Isolation

On the event of any major adverse reactions, the RRTs would coordinate the shifting of the patient to an appropriate COVID Care facility. The Chief Secretary directed to keep regular contact with the patients in home isolation.
Favipiravir
Favipiravir

Bhubaneswar: As the Odisha Government has initiated steps to start Favipiravir therapy for patients in home isolation, Chief Secretary Asit Tripathy on Monday directed the Health & Family Welfare Department to issue elaborate advisory with precautionary guidance in this regard.

Home isolation of asymptomatic and mild cases is becoming an acceptable practice among covid-19 positive persons in Odisha. Sources say, as of now near about 80% of the positive patients are preferring home isolation.

In view of this, chairing a high-level meeting over digital mode with doctors and experts, Tripathy said, “Covid-19 is an evolving crisis. The new clinical input and empirical evidence about the pandemic has proved the effectiveness of Favipiravir treatment as an antiviral therapy. It will save the patients in home isolation from getting serious. Many doctors and virus experts have posited that the medicine will be helpful in Covid management to a large extent”.

He warned that the medicine needs to be administered with proper advice and precaution and asked a team of experienced doctors to advise the patients in home isolation over audio visual media about this therapy. The patients will take the therapy under advice and guidance of physicians.

The Chief Secretary asked the Health & Family Welfare department to widely circulate the SOP on use of oral favipiravir among the doctors. The department was asked to train members of rapid response teams ( RRTs) properly for assessing the suitability of a patient in home isolation for the therapy.

Additional Chief Secretary Health & Family Welfare, Pradeepta Kumar Mohapatra, advised that the members of RRTs should properly explain the patient and his/her caregiver or family member about use of oral favipiravir, its side effects, precautions and actions to be taken by them after initiation of the therapy.

The therapy would be started only after well informed consent of the patient. The RRTs would deliver medicine, detail information sheet, ‘Dos and Don’ts’ along with ‘how and whom to report reactions/progress about patient’s condition’ at the doorstep of the patients in home isolation.

On the event of any major adverse reactions, the RRTs would coordinate the shifting of the patient to an appropriate COVID Care facility. The Chief Secretary directed to keep regular contact with the patients in home isolation.

Total
1
Shares
Related Posts